Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 5
2021 11
2022 6
2023 9
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors.
Zattarin E, Presti D, Mariani L, Sposetti C, Leporati R, Menichetti A, Corti C, Benvenuti C, Fucà G, Lobefaro R, Ligorio F, Provenzano L, Vingiani A, Del Vecchio M, Griguolo G, Sirico M, Bernocchi O, Marra A, Zagami P, Agostinetto E, Jacobs F, Di Mauro P, Esposito A, Giorgi CA, Lalli L, Boldrini L, Giacchetti PPB, Schianca AC, Guarneri V, Pedersini R, Losurdo A, Zambelli A, Generali D, Criscitiello C, Curigliano G, Pruneri G, de Braud F, Dieci MV, Vernieri C. Zattarin E, et al. Among authors: sirico m. NPJ Breast Cancer. 2023 Apr 17;9(1):27. doi: 10.1038/s41523-023-00534-1. NPJ Breast Cancer. 2023. PMID: 37069173 Free PMC article.
Advances in anti-BRAF therapies for lung cancer.
Roviello G, D'Angelo A, Sirico M, Pittacolo M, Conter FU, Sobhani N. Roviello G, et al. Among authors: sirico m. Invest New Drugs. 2021 Jun;39(3):879-890. doi: 10.1007/s10637-021-01068-8. Epub 2021 Jan 21. Invest New Drugs. 2021. PMID: 33474634 Free PMC article. Review.
Oligometastatic breast cancer and metastasis-directed treatment: an aggressive multimodal approach to reach the cure.
Merloni F, Palleschi M, Casadei C, Romeo A, Curcio A, Casadei R, Stella F, Ercolani G, Gianni C, Sirico M, Cima S, Sarti S, Cecconetto L, Di Menna G, De Giorgi U. Merloni F, et al. Among authors: sirico m. Ther Adv Med Oncol. 2023 Mar 18;15:17588359231161412. doi: 10.1177/17588359231161412. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 36950272 Free PMC article. Review.
Cancer management during the COVID-19 world pandemic.
Sobhani N, Mondani G, Roviello G, Catalano M, Sirico M, D'Angelo A, Scaggiante B, Generali D. Sobhani N, et al. Among authors: sirico m. Cancer Immunol Immunother. 2023 Nov;72(11):3427-3444. doi: 10.1007/s00262-023-03524-1. Epub 2023 Aug 29. Cancer Immunol Immunother. 2023. PMID: 37642709 Review.
Real-world clinical outcomes of patients with stage I HER2-positive breast cancer treated with adjuvant paclitaxel and trastuzumab.
Debien V, Marta GN, Agostinetto E, Sirico M, Jacobs F, Molinelli C, Moreau M, Paesmans M, De Giorgi U, Santoro A, Taylor D, Duhoux FP, Botticelli A, Barchiesi G, Speranza I, Lambertini M, Wildiers H, Azambuja E, Piccart M. Debien V, et al. Among authors: sirico m. Crit Rev Oncol Hematol. 2023 Oct;190:104089. doi: 10.1016/j.critrevonc.2023.104089. Epub 2023 Aug 9. Crit Rev Oncol Hematol. 2023. PMID: 37562696 Review.
AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption.
Sobhani N, Neeli PK, D'Angelo A, Pittacolo M, Sirico M, Galli IC, Roviello G, Nesi G. Sobhani N, et al. Among authors: sirico m. Int J Mol Sci. 2021 May 24;22(11):5515. doi: 10.3390/ijms22115515. Int J Mol Sci. 2021. PMID: 34073713 Free PMC article. Review.
29 results